|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Anergix, LLC
| | | Phone: | (310) 376-6839 | Year Established: | 2007 | Main Contact: | Lynn Foster, CEO | | Other Contacts: | David Eastman, CFO Katherine A. Louie, Ph.D., CTO & Co-Founder
| | Company Description | Anergix transduces fibroblasts with a gene designed to encode and secrete the efficacious peptide. These cells are sequestered within an implant and administered subcutaneously, in order to protect them from the immune response of the recipient and to allow removal in the event of an adverse reaction. Cells can survive for several months in vivo and provide a constant dosage of peptide. | |
|
|
|
|
|